Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs
(2022)
- Author
- Charlotte Beerts
- Promoter
- Jimmy Saunders (UGent) , Jan Spaas (UGent) and Kathelijne Peremans (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GJMZ1FVDP3QXZMX3KXGS4DNW
- MLA
- Beerts, Charlotte. Xenogeneic Use of Equine Peripheral Blood-Derived Mesenchymal Stem Cells for Treatment of Osteoarthritis in Dogs. Ghent University. Faculty of Veterinary Medicine, 2022.
- APA
- Beerts, C. (2022). Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs. Ghent University. Faculty of Veterinary Medicine, Merelbeke, Belgium.
- Chicago author-date
- Beerts, Charlotte. 2022. “Xenogeneic Use of Equine Peripheral Blood-Derived Mesenchymal Stem Cells for Treatment of Osteoarthritis in Dogs.” Merelbeke, Belgium: Ghent University. Faculty of Veterinary Medicine.
- Chicago author-date (all authors)
- Beerts, Charlotte. 2022. “Xenogeneic Use of Equine Peripheral Blood-Derived Mesenchymal Stem Cells for Treatment of Osteoarthritis in Dogs.” Merelbeke, Belgium: Ghent University. Faculty of Veterinary Medicine.
- Vancouver
- 1.Beerts C. Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs. [Merelbeke, Belgium]: Ghent University. Faculty of Veterinary Medicine; 2022.
- IEEE
- [1]C. Beerts, “Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs,” Ghent University. Faculty of Veterinary Medicine, Merelbeke, Belgium, 2022.
@phdthesis{01GJMZ1FVDP3QXZMX3KXGS4DNW,
author = {{Beerts, Charlotte}},
language = {{eng}},
pages = {{174}},
publisher = {{Ghent University. Faculty of Veterinary Medicine}},
school = {{Ghent University}},
title = {{Xenogeneic use of equine peripheral blood-derived mesenchymal stem cells for treatment of osteoarthritis in dogs}},
year = {{2022}},
}